Supplement Combination on Stress and Sleep

Description

The purpose of this clinical trial is to assess the effects of a supplement combination on measures of sleep quality and stress in healthy adults.

Conditions

Healthy

Study Overview

Study Details

Study overview

The purpose of this clinical trial is to assess the effects of a supplement combination on measures of sleep quality and stress in healthy adults.

Evaluating the Efficacy of a Supplement Combination for Improving Stress and Sleep: A Randomized Placebo-Controlled Clinical Trial

Supplement Combination on Stress and Sleep

Condition
Healthy
Intervention / Treatment

-

Contacts and Locations

Columbia

University of South Carolina Sport Science Lab, Columbia, South Carolina, United States, 29208

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Healthy participants aged 18 to 50 years (inclusive) at the time of screening with a body mass index of 18.5 to 29.9 kg/m2.
  • * Willing to give voluntary consent, be able to understand and read the questionnaires, carry out all study-related procedures, communicate effectively with the study staff, and agree to allow any study-related evaluations.
  • * Participant is physically active: participating in resistance and/or endurance exercise ≥150 min/wk for ≥6 mo.
  • * Participant will be asked about dietary supplementation use within the past 6 months.
  • * Have a known sensitivity of allergy to any of the investigational products.
  • * Participants currently taking any of the investigational products will be excluded.
  • * Female participants who are lactating, pregnant, or planning to become pregnant during the study.
  • * Diagnosed with any sleep-related or stress-related disorders.
  • * Currently taking medication to manage sleep or cortisol levels.
  • * Participants with controlled or uncontrolled hypertension including stage 1 hypertension (systolic blood pressure ≥129 mmHg and diastolic blood pressure ≥89 mmHg).
  • * Any other condition or abnormality that, in the opinion of the investigator, would compromise the safety of the participant or the quality of the study data.

Ages Eligible for Study

18 Years to 50 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of South Carolina,

Study Record Dates

2025-08-01